Showing results (391-400 of 438) with videos related to
Sort By:
Pageof 44
The American Journal of Cardiology|October 24, 2006
Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE)Pierluigi Tricoci, Eric D Peterson, Jyotsna Mulgund, et al.JAMA|September 1, 2010
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosisDeepak L Bhatt, Kim A Eagle, E Magnus Ohman, et al.Journal of Thrombosis and Thrombolysis|October 19, 2010
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trialAdriano Caixeta, Gregg W Stone, Roxana Mehran, et al.American Heart Journal|August 10, 2016
Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trialPadma Kaul, E Magnus Ohman, J David Knight, et al.JAMA|November 3, 2012
Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudyPaul A Gurbel, David Erlinge, E Magnus Ohman, et al.European Journal of Preventive Cardiology|June 16, 2026
Early versus delayed evolocumab treatment and complex coronary artery revascularizationPaul M Haller, Prakriti Gaba, Colleen Thomas, et al.Diabetes Care|June 22, 2025
Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER TrialYu Mi Kang, Robert P Giugliano, Xinhui Ran, et al.Circulation|August 3, 2016
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary InterventionAjay J Kirtane, Darshan Doshi, Martin B Leon, et al.International Journal of Cardiology|October 21, 2022
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registryJeremie Abtan, Deepak L Bhatt, Yedid Elbez, et al.Circulation. Cardiovascular Quality and Outcomes|July 9, 2015
Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 YearsKristian Kragholm, Sharif A Halim, Qinghong Yang, et al.Pageof 44